"Many newer monoclonal antibodies used in the management of various systemic disorders have been dealt with in detail in the respective chapters. The newer classifications in many disorders have been incorporated. Two new topics, one in infectious diseases chapter ‘Covid 19’ and the other in the connective tissue disorders chapter ‘Gout’ have been added. The national protocol in the management of tuberculosis, especially drug resistant tuberculosis is given in detail. The newer antiviral drugs in the management of hepatitis B and C are included. The newer drug therapy for multiple sclerosis is incorporated."

Specifications

Common questions